GLP-1 amplifies insulin signaling by up-regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 adipocytes

被引:112
作者
Gao, Hong
Wang, Xinjun
Zhang, Zhiguo
Yang, Yisheng
Yang, Jun
Li, Xiaoying
Ning, Guang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Endocrine & Metab Dis,Shanghai Clin Ctr Endo, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Endocrine & Metab Dis, Inst Hlth Sci, Shanghai 200025, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai Univ E Inst,Div Endocrinol & Metab, Shanghai 200025, Peoples R China
关键词
GLP-1; exendin; 4; insulin signaling; 3T3-L1; adipocytes;
D O I
10.1007/s12020-007-9011-4
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Glucagon-like peptide-1 (7-36) amide (GLP-1) is an insulin secretagogue. Recently, many studies have shown GLP-1 can improve insulin resistance in peripheral tissues. In the present study, we investigated glucose uptake in 3T3-L1 adipocytes in either basal or insulin resistant state and dissected insulin signaling pathway in order to elucidate the molecular mechanisms of GLP-1 mediated improvement of insulin resistance. We found GLP-1 and its long lasting analogue, exendin 4 up-regulated basal IR, IRS-1 and Glut 4 expressions although they did not increase basal glucose uptake alone. However, GLP-1 and exendin-4 increased insulin mediated glucose uptake in intact and TNF-alpha treated 3T3-L1 adipocytes by up-regulation of phophorylated IR beta, IRS-1, Akt and GSK-3 beta. These results indicate that GLP-1 and its analogue exendin-4 can amplify insulin signaling in 3T3-L1 adipocytes by up-regulation of some crucial insulin signaling molecules.
引用
收藏
页码:90 / 95
页数:6
相关论文
共 22 条
[1]
Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle [J].
Acitores, A ;
González, N ;
Sancho, V ;
Valverde, I ;
Villanueva-Peñacarrillo, ML .
JOURNAL OF ENDOCRINOLOGY, 2004, 180 (03) :389-398
[2]
ENTERAL ENHANCEMENT OF GLUCOSE DISPOSITION BY BOTH INSULIN-DEPENDENT AND INSULIN-INDEPENDENT PROCESSES - A PHYSIOLOGICAL-ROLE OF GLUCAGON-LIKE PEPTIDE-I [J].
DALESSIO, DA ;
PRIGEON, RL ;
ENSINCK, JW .
DIABETES, 1995, 44 (12) :1433-1437
[3]
GLUCAGON-LIKE PEPTIDE-1(7-36) AMIDE (GLP-1) ENHANCES INSULIN-STIMULATED GLUCOSE-METABOLISM IN 3T3-L1 ADIPOCYTES - ONE OF SEVERAL POTENTIAL EXTRAPANCREATIC SITES OF GLP-1 ACTION [J].
EGAN, JM ;
MONTROSERAFIZADEH, C ;
WANG, YH ;
BERNIER, M ;
ROTH, J .
ENDOCRINOLOGY, 1994, 135 (05) :2070-2075
[4]
Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes [J].
Fujishiro, M ;
Gotoh, Y ;
Katagiri, H ;
Sakoda, H ;
Ogihara, T ;
Anai, M ;
Onishi, Y ;
Ono, H ;
Abe, W ;
Shojima, N ;
Fukushima, Y ;
Kikuchi, M ;
Oka, Y ;
Asano, T .
MOLECULAR ENDOCRINOLOGY, 2003, 17 (03) :487-497
[5]
Effect of GLP-1 on glucose transport and its cell signalling in human myocytes [J].
González, N ;
Acitores, A ;
Sancho, V ;
Valverde, I ;
Villanueva-Peñacarrillo, ML .
REGULATORY PEPTIDES, 2005, 126 (03) :203-211
[6]
ANTIDIABETOGENIC EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE IN NORMAL SUBJECTS AND PATIENTS WITH DIABETES-MELLITUS [J].
GUTNIAK, M ;
ORSKOV, C ;
HOLST, JJ ;
AHREN, B ;
EFENDIC, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (20) :1316-1322
[7]
Effects of glucagon-like peptide-1 (7-36)amide on insulin stimulated rat skeletal muscle glucose transport [J].
Hansen, BF ;
Jensen, P ;
Nepper-Christensen, E ;
Skjolstrup, B .
ACTA DIABETOLOGICA, 1998, 35 (02) :101-103
[8]
Rosiglitazone ameliorates insulin resistance in brown adipocytes of Wistar rats by impairing TNF-α induction of p38 and p42/p44 mitogen-activated protein kinases [J].
Hernandez, R ;
Teruel, T ;
de Alvaro, C ;
Lorenzo, M .
DIABETOLOGIA, 2004, 47 (09) :1615-1624
[9]
IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance [J].
Hotamisligil, GS ;
Peraldi, P ;
Budavari, A ;
Ellis, R ;
White, MF ;
Spiegelman, BM .
SCIENCE, 1996, 271 (5249) :665-668
[10]
Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1 [J].
Idris, I ;
Patiag, D ;
Gray, S ;
Donnelly, R .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (05) :993-996